4D Molecular Therapeutics Inc (FDMT) is lower by 0.00% in a Week, Should You Sell?

4D Molecular Therapeutics Inc (FDMT) is near the top in its industry group according to InvestorsObserver. FDMT gets an overall rating of 82. That means it scores higher than 82 percent of stocks. 4D Molecular Therapeutics Inc gets a 96 rank in the Biotechnology industry. Biotechnology is number 45 out of 148 industries.

FDMT has an Overall Score of 82. Find out what this means to you and get the rest of the rankings on FDMT!

See Full FDMT Report

What do These Ratings Mean?

Searching for the best stocks to invest in can be difficult. There are thousands of options and it can be confusing on what actually constitutes a great value. InvestorsObserver allows you to choose from eight unique metrics to view the top industries and the best performing stocks in that industry. A score of 82 would rank higher than 82 percent of all stocks. These rankings allows you to easily compare stocks and view what the strengths and weaknesses are of a given company. This lets you find the stocks with the best short and long term growth prospects in a matter of seconds. The combined score incorporates technical and fundamental analysis in order to give a comprehensive overview of a stocks performance. Investors who then want to focus on analysts rankings or valuations are able to see the separate scores for each section.

What's Happening With 4D Molecular Therapeutics Inc Stock Today?

4D Molecular Therapeutics Inc (FDMT) stock is trading at $18.92 as of 2:52 PM on Friday, Mar 3, an increase of $0.79, or 4.36% from the previous closing price of $18.13. The stock has traded between $18.00 and $19.03 so far today. Volume today is less active than usual. So far 100,899 shares have traded compared to average volume of 310,918 shares. Click Here to get the full Stock Report for 4D Molecular Therapeutics Inc stock.